Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin/Etoposide vs Paclitaxel/Carboplatin With Concurrent Radiation in Stage IIIB NSCLC
DRKS00012599Phase 3Completed
- Sponsor
- Square Hospitals
- Start
- Jul 2017
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in non-small cell lung cancer (NSCLC) comparing Cisplatin + etoposide with concurrent radiotherapy with Paclitaxel + carboplatin with concurrent radiotherapy (2 arms). Started Jul 2017; status: completed.
02
Drugs
cisplatinetoposidepaclitaxelcarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on DRKS00012599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012599.